Main Menu

Pauline Kennedy speaks on pharmaceutical mergers, pricing, and business practices at Antitrust in Life Sciences conference

New York
June 30, 2022

Principal Pauline Kennedy speaks on two panels at Concurrences’ third annual Antitrust in Life Sciences Conference. The first panel, “Pricing and Business Practices in the Pharmaceutical Industry,” addresses the need for transparency to determine the extent of the damage pharmacy benefit managers’ practices are having on patients and the marketplace when drug companies raise prices as they reach the end of patent exclusivity. Dr. Kennedy’s co-panelist is Michael Cowie of Dechert, and the moderator is Thomas Horton of the University of South Dakota.

In the second panel, “Recent Developments in the US and the EU,” panel members will discuss the best ways for agencies to review and update the analysis of pharmaceutical mergers in light of the 2021 launch of the Multilateral Pharmaceutical Merger Task Force by the Federal Trade Commission, Department of Justice, Canada’s Competition Bureau, DG COMP, and the CMA. Dr. Kennedy’s co-panelists include—

The full agenda 2022 is available here.

Jump to Page

We use cookies to optimize the performance of this site and give you the best user experience. By clicking "Accept," you agree to our use of cookies.

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.